Park, Sohee
Hwang, Hye Jeon https://orcid.org/0000-0003-3508-2870
Yun, Jihye
Chae, Eun Jin
Choe, Jooae
Lee, Sang Min
Lee, Han Na
Shin, So Youn
Park, Heejun
Jeong, Hana
Kim, Min Jee
Lee, Jang Ho
Jo, Kyung-Wook
Baek, Seunghee
Seo, Joon Beom
Article History
Received: 13 January 2025
Revised: 3 April 2025
Accepted: 22 April 2025
First Online: 22 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Hye Jeon Hwang.
: Joon Beom Seo declares relationships with the following companies: Stockholder, Coreline Soft Co. (Medical software company)/Promedius Co. (Medical AI company, co-founder, CMO)/Anymedi Co. (Medical 3D printing company). Royalty for technical transfer, Vuno (Medical AI company), Coreline, Promedius. Chief Medical Officer, Promedius. Joon Beom Seo holds a patent on a method for an automatic classifier of lung diseases (Patent No. KR-10-0998630). The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Seunghee Baek, one of the authors, has significant statistical expertise and provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Among 587 patients, 11 were included from a previously described study population [reference ], in which the value of a proposed CBIR system for the diagnosis of four disease classes of ILD (UIP, nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, and chronic hypersensitivity pneumonitis) was evaluated. In the present study, the same CBIR system was examined for UIP CT pattern classifications.
: